Katarina Vasiljević

Dr. Katarina Vasiljević


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Vesna ŠuljagićVesna Šuljagić
Vesna Šuljagić
VNVojislava Neskovic
Vojislava Neskovic
DMDuško Maksimović
Duško Maksimović
IUIvo Udovičić
Ivo Udovičić
DPDanijela Đurić Petković
Danijela Đurić Petković
Nemanja RancicNemanja Rancic
Nemanja Rancic
Background: Healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and antibiotic use (AU) remain critical challenges in intensive care units (ICUs). Reliable long-term surveillance is essential to inform stewardship programs and infection prevention. Methods: We conducted a seven-year ecological study (2018–2024) of adult patients admitted to the surgical ICU of a Serbian tertiary university hospital. Patients with ICU stays >48 h were included. Data on demographics, HAIs, AU expressed as ‘days of therapy’ (DOT) per 100 patient-days, and resistance profiles of key pathogens were collected. AU was classified by WHO Access, Watch and Reserve categories. Trends were analyzed, and correlations between AU and healthcare-associated Clostridioides difficile infection (HA-CDI) incidence density as well as changes in AMR rates were assessed. Direct expenditures for antibiotic therapy were also calculated. Results: Among 2055 patients, 511 (24.9%) developed at least one HAI. HA-CDI showed a marked upward trend. Overall, AU was stable, but Reserve antibiotics increased significantly (R2 = 0.456), particularly linezolid, colistin, and ceftazidime–avibactam. Resistance to carbapenems and colistin in Klebsiella pneumoniae (K. pneumonia) demonstrated alarming trends. A strong correlation was observed between colistin use and colistin resistance in K. pneumoniae. Antibiotic expenditures peaked in 2023 at more than double pre-COVID levels, mainly driven by Reserve agents. Conclusions: This study reveals a concerning rise in multidrug-resistant pathogens, escalating Reserve antibiotic use, and substantial financial burden. Strengthened antimicrobial stewardship, optimization of Access, restriction of Reserve agents, and investment in infection prevention and surveillance are urgently needed.